<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; era</title>
	<atom:link href="http://www.tapanray.in/tag/era/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Access Denied, Ethics Demanded: India’s Pharma Detailing at a Turning Point</title>
		<link>http://www.tapanray.in/beyond-influence-a-new-era-of-ethical-medical-detailing-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=beyond-influence-a-new-era-of-ethical-medical-detailing-in-india</link>
		<comments>http://www.tapanray.in/beyond-influence-a-new-era-of-ethical-medical-detailing-in-india/#comments</comments>
		<pubDate>Fri, 13 Jun 2025 00:00:28 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[beyond]]></category>
		<category><![CDATA[branded]]></category>
		<category><![CDATA[detailing]]></category>
		<category><![CDATA[DGHS]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[era]]></category>
		<category><![CDATA[ethical]]></category>
		<category><![CDATA[generics]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[influence]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[limitations]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[patented]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[representation]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10913</guid>
		<description><![CDATA[June 11, 2025 — The Economic Times reports that a prominent pharmaceutical industry association has urged the Union Health Ministry to reconsider its directive that bars medical representatives (MRs) from physically meeting doctors in central government hospitals. The industry argues that the move &#8230; <a href="http://www.tapanray.in/beyond-influence-a-new-era-of-ethical-medical-detailing-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/beyond-influence-a-new-era-of-ethical-medical-detailing-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer Care: Dawns A New Era Of Precision Medicine In India</title>
		<link>http://www.tapanray.in/cancer-care-dawns-a-new-era-of-precision-medicine-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cancer-care-dawns-a-new-era-of-precision-medicine-in-india</link>
		<comments>http://www.tapanray.in/cancer-care-dawns-a-new-era-of-precision-medicine-in-india/#comments</comments>
		<pubDate>Mon, 22 Aug 2016 00:00:22 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[biomarker]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[dawn]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[era]]></category>
		<category><![CDATA[genome]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[ICMR]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Intellectual]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[one-size-fits-all]]></category>
		<category><![CDATA[personalized]]></category>
		<category><![CDATA[Pharmacogenomics]]></category>
		<category><![CDATA[Precision]]></category>
		<category><![CDATA[Property]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sequencing]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7779</guid>
		<description><![CDATA[The concept of ‘Precision Medicine’ has started gaining increasing importance, in the treatment process of many serious diseases, such as cancer. It is now happening in many countries of the world, including India. The National Institutes of Health (NIH) of &#8230; <a href="http://www.tapanray.in/cancer-care-dawns-a-new-era-of-precision-medicine-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/cancer-care-dawns-a-new-era-of-precision-medicine-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer and Biocon deal – heralds dawn of a new era for the Biopharmaceuticals Industry of India</title>
		<link>http://www.tapanray.in/pfizer-and-biocon-deal-heralds-dawn-of-a-new-era-for-the-biopharmaceuticals-industry-of-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pfizer-and-biocon-deal-heralds-dawn-of-a-new-era-for-the-biopharmaceuticals-industry-of-india</link>
		<comments>http://www.tapanray.in/pfizer-and-biocon-deal-heralds-dawn-of-a-new-era-for-the-biopharmaceuticals-industry-of-india/#comments</comments>
		<pubDate>Thu, 25 Nov 2010 03:41:50 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[analogue]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Biocon]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[dawn]]></category>
		<category><![CDATA[deal]]></category>
		<category><![CDATA[era]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[heralds]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[insulin]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=357</guid>
		<description><![CDATA[On October 19, 2010, home grown Biotech Company Biocon, based in the IT heartland – Bangalore created a stir in Industry by inking an interesting international corporate business deal with the largest global pharmaceutical company &#8211; Pfizer. The deal will &#8230; <a href="http://www.tapanray.in/pfizer-and-biocon-deal-heralds-dawn-of-a-new-era-for-the-biopharmaceuticals-industry-of-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pfizer-and-biocon-deal-heralds-dawn-of-a-new-era-for-the-biopharmaceuticals-industry-of-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
